SNDX
Syndax Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +5.3% ·
Aktienfluss +8.0% ·
neue Nettopositionen +5.0%
· Formel
Breite Akkumulation: steigende Aktienanzahl bei mehr Inhabern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 62.71K | $1.14M | n/a | n/a |
| Q2 2026 | 93 | 0 | 57.47M | $1.26B | +9 | −10 |
| Q1 2026 | 97 | +6 | 52.14M | $1.22B | +10 | −4 |
| Q4 2025 | 91 | -3 | 57.71M | $1.21B | n/a | −3 |
| Q3 2025 | 20 | +1 | 39.69M | $610.59M | +1 | n/a |
| Q2 2025 | 16 | +1 | 29.55M | $276.77M | +1 | n/a |
| Q1 2025 | 12 | -1 | 16.71M | $205.25M | n/a | −1 |
| Q4 2024 | 13 | +1 | 16.01M | $211.65M | +1 | n/a |
| Q3 2024 | 11 | -1 | 14.02M | $269.82M | n/a | −1 |
| Q2 2024 | 12 | n/a | 17.35M | $356.12M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 8.63M | -17.5% | $132.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | Goldman Sachs Group ✦ | 5.49M | n/a | $84.41M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 3 | The Vanguard Group ✦ (passiv) | 5.14M | +2.1% | $79.06M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | Point72 Asset Management ✦ | 4.26M | +100.0% | $65.46M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passiv) | 3.85M | +11.9% | $59.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 3.31M | +131.2% | $50.95M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 2.09M | +2.0% | $32.18M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 1.20M | n/a | $18.45M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | D. E. Shaw & Co. ✦ | 1.08M | +67.2% | $16.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 1.05M | -34.5% | $16.10M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 860.50K | +2.7% | $13.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 712.66K | +27.9% | $10.96M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 558.08K | +142.0% | $8.59M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 14 | Citadel Advisors ✦ | 546.27K | -14.7% | $8.40M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | JPMorgan Chase ✦ | 507.70K | n/a | $7.81M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 16 | Marshall Wace ✦ | 233.97K | +0.8% | $3.60M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | T. Rowe Price ✦ | 91.13K | +20.9% | $1.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 48.25K | Neu | $742,265 | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 38.23K | +12.2% | $588,107 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 20 | Fidelity (FMR) ✦ | 5.10K | -96.8% | $78,477 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Gotham Asset Management | $742,265 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 244 Inhaber, 99.11M Anteile, $2.29B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.